Al's Comment:

 They show a significant benefit when combining these 2 treatments in the lab.  Each had a strong effect by themselves, but the combination was much better.    As noted in the article, it should first be trested if AZD1152 gets to the tumor in the right concentration - might be a good combination to try in a phase 0 trial.

Posted on: 03/12/2023

Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas


Click HERE to return to brain tumor news headlines.

Our privacy / cookie policy has changed.
Click HERE to read it!